Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Achilles heel: Popular drug-carrying nanoparticles get trapped in bloodstream

Katawut Namdee, BME Ph.D. student, performs tests with different forms of drug carriers as part of the research done in ChE Professor Omolola Eniola Adefesco's lab in the GG Brown Building on North Campus Ann Arbor, MI on December 17, 2012. Image credit: Joseph Xu, Michigan Engineering Communications & Marketing
Katawut Namdee, BME Ph.D. student, performs tests with different forms of drug carriers as part of the research done in ChE Professor Omolola Eniola Adefesco's lab in the GG Brown Building on North Campus Ann Arbor, MI on December 17, 2012.

Image credit: Joseph Xu, Michigan Engineering Communications & Marketing

Abstract:
Many medically minded researchers are in hot pursuit of designs that will allow drug-carrying nanoparticles to navigate tissues and the interiors of cells, but University of Michigan engineers have discovered that these particles have another hurdle to overcome: escaping the bloodstream.

Achilles heel: Popular drug-carrying nanoparticles get trapped in bloodstream

Ann Arbor, MI | Posted on February 5th, 2013

Drug delivery systems promise precision targeting of diseased tissue, meaning that medicines could be more effective at lower doses and with fewer side effects. Such an approach could treat plaques in arteries, which can lead to heart attacks or strokes.

Drug carriers would identify inflamed vessel walls and deliver a drug that removes the deposits of calcium, cholesterol and other substances. Or, the carriers might seek out markers of cancer and kill off the small blood vessels in tumors, starving the malignant tissue of food and oxygen.

Nanoparticles, which have diameters under one micron, or one-thousandth of a millimeter, are thought to be the most promising drug carriers. Omolola Eniola-Adefeso, U-M professor of chemical engineering who studies nanoparticles in flowing blood, says the immune system can't get rid of them quickly.

"It's hard for a white blood cell to understand it has a nanoparticle next to it," she said.

Those same tiny dimensions allow them to slip through the cracks between cells and infiltrate cell membranes, where they can go to work administering medicine. But Eniola-Adefeso and her team found that these particles have an Achilles heel.

Blood vessels are the body's highways, and once nanoparticles get into the flow, they find it very difficult to reach the exits. In all vessels other than capillaries, the red cells in flowing blood tend to come together in the center.

"The red blood cells sweep those particles that are less than one micron in diameter and sandwich them," she said.

Trapped among the red cells, the nanoparticles can't reach the vessel wall to treat disease in the blood vessels or the tissue beyond.

With their recent work, including a study to be published recently in Langmuir, Eniola-Adefeso's team has shown that nanoparticle spheres face this problem in tiny arterioles and venules—one step up from capillaries—all the way up to centimeter-sized arteries.

They discovered this with the help of plastic channels lined with the same cells that make up the interiors of blood vessels. Human blood, with added nano- or microspheres, ran through the channels, and the team observed whether or not the spheres migrated to the channel walls and bound themselves to the lining. The researchers present the first visual evidence that few nanospheres make it to the vessel wall in blood flow.

"Prior to the work that we have done, people were operating under the assumption that particles will interact with the blood vessel at some point," Eniola-Adefeso said.

While a relatively small fraction of nanospheres filter out to the blood vessel walls, many more stay in the bloodstream and travel all over the body. Increasing the nanoparticle dose gives poor returns; after the team added five times more nanospheres to the blood samples, the number of spheres that bonded with the blood vessel lining only doubled.

"If localized drug delivery is an important goal, then nanospheres will fail," she said.

But it's not all bad news. The red blood cells tended to push microspheres with diameters of two microns or more toward the wall. Whether the blood flowed evenly, as it does in arterioles and venules, or in pulses, as occurs in arteries, the larger microspheres were able to reach the vessel wall and bind to it. When the team added more microspheres to the flow, they saw a proportional increase in microspheres on the vessel wall.

While microspheres are too large to serve as drug carriers into cell or tissue space on their own, the team suggested that microspheres could ferry nanospheres to the vessel wall, releasing them upon attachment. But the simpler approach may be nanoparticles of different shapes, which might escape the red blood cells on their own.

Eniola-Adefeso and her team are experimenting with rod-shaped nanoparticles.

"A sphere has no drift," she said, so nanospheres won't naturally move sideways out of the red cell flow. "When a rod is flowing, it drifts, and that drift moves it closer to the vessel wall."

####

For more information, please click here

Contacts:
Kate McAlpine

734-763-4386

Copyright © University of Michigan

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

The newest paper titled "Margination Propensity of Vascular-Targeted Spheres from Blood Flow in a Microfluidic Model of Human Microvessels" is published online at:

The Cell Adhesion and Drug Delivery Lab:

Related News Press

News and information

Scientists Capture Ultrafast Snapshots of Light-Driven Superconductivity: X-rays reveal how rapidly vanishing 'charge stripes' may be behind laser-induced high-temperature superconductivity April 16th, 2014

'Life Redesigned: The Emergence of Synthetic Biology' Lecture at Brookhaven Lab on Wednesday, April 30: Biomedical Engineer James Collins to Speak for BSA Distinguished Lecture Series April 16th, 2014

ECHA Planning Workshop on Regulatory Challenges in the Risk Assessment of Nanomaterials April 16th, 2014

Lumerical files a provisional patent that extends the standard eigenmode expansion propagation technique to better address waveguide component design. Lumerical’s EME propagation tool will address a wide set of waveguide applications in silicon photonics and integrated optics April 16th, 2014

Govt.-Legislation/Regulation/Funding/Policy

'Life Redesigned: The Emergence of Synthetic Biology' Lecture at Brookhaven Lab on Wednesday, April 30: Biomedical Engineer James Collins to Speak for BSA Distinguished Lecture Series April 16th, 2014

ECHA Planning Workshop on Regulatory Challenges in the Risk Assessment of Nanomaterials April 16th, 2014

UT Arlington physicist creates new nanoparticle for cancer therapy April 16th, 2014

Relieving electric vehicle range anxiety with improved batteries: Lithium-sulfur batteries last longer with nanomaterial-packed cathode April 16th, 2014

Nanomedicine

UT Arlington physicist creates new nanoparticle for cancer therapy April 16th, 2014

Nanobiotix Appoints Thierry Otin as Head of Manufacturing and Supply April 15th, 2014

PAM-XIAMEN Offers UV LED wafer April 15th, 2014

Nanocrystalline cellulose modified into an efficient viral inhibitor April 15th, 2014

Discoveries

Scientists Capture Ultrafast Snapshots of Light-Driven Superconductivity: X-rays reveal how rapidly vanishing 'charge stripes' may be behind laser-induced high-temperature superconductivity April 16th, 2014

Scientists observe quantum superconductor-metal transition and superconducting glass: A team including MIPT physicist observed quantum superconductor-metal transition and superconducting glass April 16th, 2014

UT Arlington physicist creates new nanoparticle for cancer therapy April 16th, 2014

Targeting cancer with a triple threat: MIT chemists design nanoparticles that can deliver three cancer drugs at a time April 15th, 2014

Announcements

UT Arlington physicist creates new nanoparticle for cancer therapy April 16th, 2014

Relieving electric vehicle range anxiety with improved batteries: Lithium-sulfur batteries last longer with nanomaterial-packed cathode April 16th, 2014

Aerotech X-Y ball-screw stage for economical high performance Planar positioning April 16th, 2014

Energy Research Facility Construction Project at Brookhaven Lab Wins U.S. Energy Secretary's Achievement Award April 16th, 2014

Safety-Nanoparticles/Risk management

ECHA Planning Workshop on Regulatory Challenges in the Risk Assessment of Nanomaterials April 16th, 2014

Effects of Carbon Nanotubes Studied on Pregnant Mothers April 12th, 2014

Local girl does good March 22nd, 2014

Scientists Study Possibility of Migration of Nanoparticles from Foodstuff Packaging to Products March 16th, 2014

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

Energy Research Facility Construction Project at Brookhaven Lab Wins U.S. Energy Secretary's Achievement Award April 16th, 2014

IDTechEx Printed Electronics Europe 2014 Award Winners April 1st, 2014

Dais Analytic Wins SBIR Grant: Dais Analytic Receives US Army Small Business Innovation Research Grant to Further Its Demonstrated Successes in Cleaning Most Forms of Wastewater March 28th, 2014

Scientists develop world’s first light-activated antimicrobial surface that also works in the dark March 24th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE